GLP-1 Benefits Beyond Weight Loss: IBS, PCOS, and Risks

By now, most people are familiar with GLP-1 medications for weight loss.

But newer research is expanding the conversation.

GLP-1 medications may affect gut function, appetite signaling, and metabolic health, but also have clear limitations.

Let’s take a closer look at the evidence.

What Are GLP-1s & How Do They Work? 

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in the gut and brain, primarily in response to eating.

It plays a central role in coordinating how your body handles food by 1:

• Stimulating insulin release when blood sugar rises
• Reducing glucagon (which would otherwise raise blood sugar)
• Slowing how quickly food leaves the stomach
• Increasing feelings of fullness after meals

GLP-1 receptor agonists are medications designed to mimic this hormone, but with a longer-lasting effect.

While your natural GLP-1 response lasts minutes, these medications can remain active for hours or even days. This extended activity is what drives their more noticeable effects on appetite, blood sugar regulation, and digestion.

At a systems level, GLP-1 signaling connects the gut, pancreas, and brain. It influences not only how you process food, but also how hungry you feel, how quickly you become full, and how your body responds metabolically after eating 2 3.

This combination of effects is what makes GLP-1 therapies useful for blood sugar control and weight loss, and may also explain why researchers are now exploring their impact in other areas.

GLP-1 Benefits Beyond Weight Loss

Most of the attention around GLP-1 medications has focused on weight loss.

But researchers are now looking at how these drugs affect other systems, including the gut, brain, and hormone regulation.

Some of these effects appear to come directly from GLP-1 signaling. Others may be secondary to changes in weight, metabolism, or food intake.

Here’s where the research is starting to show potential.

Emerging Benefits for Irritable Bowel Syndrome 

One of the more unexpected areas of research is irritable bowel syndrome (IBS).

A 2024 systematic review found that GLP-1 receptor agonists may help reduce abdominal pain and improve bowel habits in people with IBS 4. These effects appeared across multiple IBS subtypes, with some of the strongest signals in IBS-C and mixed-type IBS. However, they did come with side effects like nausea, vomiting, and headache.

In a randomized controlled trial (gold standard type of study) of 166 patients, a GLP-1 analog (ROSE-010) led to significantly greater pain relief compared to placebo 5. Patients also reported faster symptom relief, often within 10 to 60 minutes.

Researchers believe this may be due to how GLP-1 affects the gut by:

• Slowing motility
• Modulating nerve signaling
• Possibly reducing visceral hypersensitivity (pain response)

There is also some early evidence that GLP-1 medications may reduce overall IBS symptom severity and medication use, although more long-term data is needed 6.

At the same time, side effects like nausea and vomiting are common, which may limit tolerance for some patients.

Overall, GLP-1 therapies may help calm certain aspects of IBS, particularly pain signaling, but they are not currently a first-line treatment and likely need to be used selectively.

Potential Benefits for Addiction 

Another area getting attention is how GLP-1 medications affect cravings and reward-driven behavior.

These drugs don’t just act in the gut. They also signal in key brain areas involved in appetite, motivation, and reward.

Preclinical and early human research suggests GLP-1 signaling may influence dopamine pathways, which play a central role in how we experience reward and reinforcement 7.

Specifically, GLP-1 activity has been observed in areas like 8:

• The hypothalamus, which regulates appetite
• The brainstem, which connects gut signals to the brain
• The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings

Through these pathways, GLP-1 medications may:

• Reduce food cravings and “food noise”
• Change how rewarding certain foods feel
• Lower motivation to seek out highly palatable foods

There is also emerging interest in whether these effects extend beyond food.

Early research suggests GLP-1 signaling may influence alcohol intake and other addictive behaviors, although most of this evidence is still preliminary and based on animal models or small human studies.

Overall, GLP-1 therapies appear to interact with the same systems that drive cravings and reward. This may help explain why some patients report a noticeable shift in how they think about food and, potentially, other substances.

At this stage, the evidence is still developing, and these medications are not used as primary treatments for addiction. But this is an area to watch as more research emerges.

May Support PCOS

GLP-1 medications are also being studied for their role in polycystic ovary syndrome (PCOS), particularly in patients with insulin resistance.

Since many cases of PCOS are driven, in part, by impaired insulin signaling, improving metabolic function may have downstream effects on hormone balance and ovulation.

A number of studies have found that GLP-1 receptor agonists can 9:

• Reduce body weight and waist circumference
• Improve insulin resistance (measured by HOMA-IR)
• Lower fasting glucose and insulin levels

These changes may contribute to improvements in ovulatory function and menstrual regularity, particularly in individuals with overweight or obesity.

Some research also suggests that GLP-1 therapies may indirectly reduce androgen levels by improving insulin sensitivity, which is a key driver of hormonal imbalance in PCOS 10 11.

In clinical practice, these medications are generally not considered first-line treatment for PCOS. They are more commonly used in cases where lifestyle interventions and medications like metformin have not led to sufficient improvement 12.

There is also some evidence that GLP-1 receptor agonists can be used alongside metformin safely, although long-term data is still evolving.

Overall, GLP-1 therapies may offer a useful option for certain patients with PCOS, especially when metabolic dysfunction is a central feature. However, their benefits appear to be closely tied to improvements in weight and insulin regulation, rather than a direct effect on reproductive hormones alone.

The Original Use: Diabetes 

Before gaining attention as a weight loss strategy, GLP-1 receptor agonists were developed to help manage type 2 diabetes.

They lower blood sugar through several coordinated effects, including 13:

• Increasing insulin release when blood sugar rises
• Reducing glucagon, which would otherwise raise blood sugar
• Slowing gastric emptying, which helps limit post-meal spikes

Because these effects are glucose-dependent, the risk of hypoglycemia is relatively low compared to some other diabetes medications.

In clinical trials, GLP-1 therapies have been shown to 14:

• Reduce HbA1C (a snapshot of blood sugar over three months)
• Support weight loss
• Improve overall metabolic control

They are often used when first-line treatments like metformin are not enough, or when weight loss and cardiometabolic risk are key considerations.

This metabolic foundation helps explain many of the broader effects discussed earlier. In many cases, improvements in blood sugar regulation, weight, and insulin sensitivity appear to drive downstream benefits in other systems.

Secondary (Weight-Mediated) Benefits

Some of the broader health improvements seen with GLP-1 medications may not come from the drug itself, but from the changes it creates.

Weight loss, improved insulin sensitivity, and reduced inflammation can all have wide-ranging beneficial effects throughout the body. As these improve, other conditions often improve alongside them.

This makes it difficult to separate what’s a direct effect of GLP-1 signaling from what’s a result of better overall metabolic health.

Here are a few areas where this shows up:

Kidney Health

Large randomized trials have found that GLP-1 receptor agonists are associated with a reduced risk of chronic kidney disease progression and kidney failure 15.

A meta-analysis of over 80,000 patients reported 16:

• 16% reduction in kidney failure risk
• 18% reduction in worsening kidney function

These benefits are thought to be largely driven by improvements in:

• Blood sugar control
• Blood pressure
• Body weight and inflammation 

Fertility and Reproductive Function

GLP-1 therapies have also been linked to improvements in fertility outcomes, particularly in individuals with obesity or insulin resistance.

Some studies have found that GLP-1 receptor agonist medications can 17:

• Improve ovulation and menstrual regularity
• Increase pregnancy rates in certain populations

These effects appear to be largely mediated by:

• Improved insulin sensitivity
• Reduced androgen levels
• A more stable metabolic environment

Cardiometabolic Health

GLP-1 receptor agonists have consistently been shown to improve cardiometabolic risk markers.

These include 18:

• Reduced body weight and visceral fat
• Improved blood sugar control
• Lower risk of major cardiovascular events such as heart attack and stroke

While some of these effects may be partially drug-specific, a significant portion appears to be linked to weight loss and improvements in metabolic function.

Putting This Into Context

GLP-1 medications can create meaningful improvements across multiple systems. But in many cases, those improvements are connected.

As weight, blood sugar, and insulin regulation improve, other areas like kidney function, fertility, and cardiovascular risk often improve alongside them.

This doesn’t make the benefits less meaningful, but it does help clarify where they’re coming from.

Potential GLP-1 Downsides and Risks

GLP-1 medications can be effective, but they are not without tradeoffs. The most common issues are gastrointestinal side effects.

In clinical studies and real-world use, patients frequently report:

• Nausea
• Diarrhea
• Vomiting

These symptoms are often most noticeable when starting the medication or increasing the dose. In some cases, they improve over time, but not always.

Another important consideration is how these medications affect overall food intake.

Because GLP-1 therapies significantly reduce appetite, many people eat less. While this can support weight loss, it can also lead to unintended gaps in nutrition.

A recent review found that patients using GLP-1 medications may be at increased risk for 19:

• Low protein intake
• Reduced intake of key micronutrients like vitamin D, iron, and calcium
• Declines in vitamin B12 and thiamine (B1) over time

In some cases, this may contribute to:

• Fatigue or low energy
• Loss of lean muscle mass
• Longer-term nutrient deficiencies, if not addressed

This is not a reason to avoid these medications, but it does highlight the importance of dietary quality and intentional nutrition support from a qualified professional while using them.

There are also broader considerations.

Not everyone responds the same way to GLP-1 therapies, and some individuals may find the side effects outweigh the benefits. Long-term data is still evolving, particularly as these medications are used more widely outside of diabetes care.

GLP-1 FAQs

Do GLP-1s Have Benefits Beyond Diabetes and Weight Loss? 

Possibly. Emerging research suggests GLP-1 medications may affect more than blood sugar and body weight. Studies have explored potential benefits for IBS symptoms, appetite and craving regulation, and metabolic aspects of conditions like PCOS.

However, the strength of evidence varies.

Some areas, like blood sugar control and weight loss, are well established. Others are still developing and may depend on indirect effects, such as improvements in weight, insulin sensitivity, or overall metabolic health.

At this stage, GLP-1s are not considered first-line treatments for conditions outside of diabetes and obesity, but research in these areas is ongoing.

What Do GLP-1s Really Do To Your Body?

GLP-1 medications act on multiple systems at once.

They:

• Increase insulin release when blood sugar rises
• Decrease glucagon, which helps prevent blood sugar spikes
• Slow gastric emptying, so food moves more gradually through the digestive tract
• Increase feelings of fullness and reduce appetite
• Signal in the brain to influence hunger, cravings, and reward

Together, these effects change how your body processes food, regulates energy, and responds to hunger signals.

This is why people often experience reduced appetite, improved blood sugar control, and weight loss, along with other downstream effects.

Are GLP-1s Bad For You? 

Not inherently, but they are not risk-free.

For many people, GLP-1 medications can be a useful tool, particularly for managing blood sugar or supporting weight loss.

However, they come with potential downsides.

Common side effects include nausea, diarrhea, and vomiting. Over time, reduced appetite may also lead to lower intake of protein and key nutrients if the diet is not managed intentionally.

Considering GLP-1s For Benefits Beyond Weight

GLP-1 medications are expanding how we think about metabolic health.

Beyond their established role in blood sugar control and weight loss, research is exploring effects on the gut, brain, and hormone regulation. Some findings are promising, particularly for symptoms tied to appetite and insulin resistance. At the same time, many of these benefits appear to be driven by broader improvements in weight and metabolic health, not just the medication itself.

These therapies also come with tradeoffs, including gastrointestinal side effects and the potential for nutrient gaps if food intake drops too low. Outcomes tend to be better when they are used as part of a broader plan that includes adequate nutrition and ongoing support.

If you’re considering GLP-1 therapy or trying to decide whether it’s the right fit for your symptoms, working with a clinician can help you take a more personalized, sustainable approach. If you’d like guidance, you can schedule a consultation with our clinic to map out the best next step for you. We’d love to help you at the Ruscio Clinic. Book a consultation today.

Dr. Michael Ruscio is a DC, natural health provider, researcher, and clinician. He serves as an Adjunct Professor at the University of Bridgeport and has published numerous papers in scientific journals as well as the book Healthy Gut, Healthy You. He also founded the Ruscio Institute of Functional Health, where he helps patients with a wide range of GI conditions and serves as the Head of Research.